Company Number: 14368466

Analysis Date: 2025-07-29 13:33 UTC

Financial Health Assessment of PUREVEGI LTD as of 30 September 2024

---

1. Financial Health Score: D

• Explanation: The company currently shows significant financial distress, demonstrated by negative net assets and a sharp deterioration in working capital. Despite being a relatively new business (incorporated in 2022), the financial "vital signs" indicate symptoms of liquidity strain and capital erosion, warranting a grade of D to reflect the need for urgent financial attention and remedial action.

---

2. Key Vital Signs

Metric	2024 (£)	2023 (£)	Interpretation
Fixed Assets	34,384	34,384	Stable long-term asset base, no impairment
Current Assets	6,646	26,550	Significant drop, mainly cash depletion
Cash	4,415	24,608	Healthy cash flow in 2023 but severe reduction in 2024, symptom of cash flow distress
Debtors	1,320	1,320	Stable, no increase in receivables, neutral
Current Liabilities	51,870	53,490	Slight improvement but still high short-term debts
Net Current Assets (Working Capital)	(45,224)	(26,940)	Negative and worsening, indicating liquidity issues
Net Assets (Shareholders’ Funds)	(10,840)	7,444	Shift from positive equity to negative, indicating capital erosion
Share Capital	100	100	Minimal share capital, typical for micro entities

Interpretation of Vital Signs:

• Cash Flow "Pulse": The sharp decline in cash from £24,608 to £4,415 is a red flag. This symptom indicates the company is burning through cash rapidly, possibly due to operational losses or increased payments.
• Working Capital "Breathlessness": Negative net current assets (-£45k) reveal the company owes more in the short term than it owns in liquid assets, a sign of liquidity distress.
• Capital "Heart" Condition: Transition from positive net assets in 2023 to negative net assets in 2024 indicates the company is technically insolvent on a balance sheet basis, putting the business at risk if this trend continues.

---

3. Diagnosis

PUREVEGI LTD is currently in a precarious financial state, showing clear symptoms of liquidity strain and capital erosion within its first two years of trading. The decrease in cash reserves coupled with a growing working capital deficit signals a challenge in meeting short-term obligations—akin to a patient experiencing difficulty breathing and a weak heartbeat.

The negative shareholders’ funds suggest that the company has consumed retained earnings or incurred losses that have depleted equity. While fixed assets remain stable, their illiquidity means they cannot be quickly converted into cash to relieve current pressures.

Overall, the company’s financial health is compromised by cash flow weakness and insufficient short-term asset coverage of liabilities, which if unresolved, could lead to insolvency risks.

---

4. Recommendations

To restore financial wellness and improve the "vital signs" of PUREVEGI LTD, consider the following specific actions:

• Liquidity Management

  • Improve cash flow monitoring and forecasting to prevent further cash depletion.
  • Negotiate extended payment terms with creditors to ease immediate cash pressure.
  • Accelerate collection of debtors and review credit policy to enhance cash inflow.

• Cost Control

  • Conduct a thorough expense review to identify and cut non-essential costs, reducing cash burn.
  • Optimize inventory management to prevent overstocking and free up working capital.

• Capital Injection

  • Consider raising additional equity or shareholder loans to shore up net assets and provide a buffer.
  • Explore external financing options such as short-term credit facilities or government-backed loans.

• Operational Review

  • Analyze revenue streams and pricing strategy to improve turnover and gross margins.
  • Investigate operational efficiency improvements to reduce overheads.

• Regular Financial Health Monitoring

  • Implement monthly financial reviews focusing on cash flow, working capital, and profitability trends.
  • Seek professional advice if signs of distress persist to avoid insolvency.

---

Executive Summary

Purevegi Ltd is currently facing significant financial challenges, evidenced by a steep decline in cash reserves and a negative working capital position, leading to negative net assets. These symptoms point to liquidity stress and capital erosion, requiring urgent cash flow management and potential capital injection to restore financial health and avoid insolvency risks.